Poland· PL-100524008
Rezdiffra
A liver therapy product containing resmetirom, registered in Poland by Madrigal Pharmaceuticals EU Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Resmetirom is registered in 3 of 19 countries.
Countries holding a registration under ATC A05BA (liver therapy), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Resmetirom · ATC A05BA
3 / 19 countries
- Belgiumprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Resmetirom
- Manufacturer
- Madrigal Pharmaceuticals EU Limited
- Country
- Poland (PL)
- ATC code
- A05BA
- ATC class
- Liver therapy
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin08721516514004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Resmetirom in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRezdiffra 60 mgMadrigal Pharmaceuticals EU
- CzechiaREZDIFFRAMadrigal Pharmaceuticals EU Limited, Dublin
- SpainREZDIFFRA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMadrigal Pharmaceuticals Eu Limited
- FinlandRezdiffraMadrigal Pharmaceuticals EU Limited
- FranceREZDIFFRA 60 mg, comprimé pelliculéMADRIGAL PHARMACEUTICALS EU (IRLANDE)
- IrelandRezdiffra 60 mg film-coated tabletsMadrigal Pharmaceuticals EU Limited
- IcelandRezdiffraMadrigal Pharmaceuticals EU Limited
- NetherlandsRezdiffra 60 mg filmomhulde tablettenMadrigal Pharmaceuticals EU Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/02473465-c900-49dc-bc40-40d17f72c634 GET /v1/drugs/02473465-c900-49dc-bc40-40d17f72c634?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "60 mg",
"packaging": "08721516514004 ¦ Rp ¦ EU/1/25/1962/001 ¦ 163552\n28 tabl.",
"substance": "Resmetirom 60 mg",
"common_name": "Resmetirom",
"pl_product_id": "100524008",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about resmetirom.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.